Xiaomei Leng, MD, PhD

NA
Beijing, Beijing, China

Professor Xiaomei Leng, from the Department of Rheumatology and Clinical Immunology of Peking Union Medical College Hospital, in China.

Disclosure information not submitted.

Presentation(s):

• 0917: Fifty-two-week Results from a Phase 3, Randomized, Double-blind, Active-controlled Clinical Trial to Compare BAT1806/BIIB800, a Proposed Tocilizumab Biosimilar, with a Tocilizumab Reference Product in Subjects with Moderate to Severe RA with an Inadequate Response to Methotrexate

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time